Taiwan FDA registration 05eb9cda006e6cf052f2511e891eee46
Boy's second-generation blood glucose measurement system
TW: 博依第二代血糖量測系統
Taiwan·Risk Class 2·EPS BIO TECHNOLOGY CORP.·Registered May 21, 2013 – Jun 01, 2022CancelledRegistration details
- Analysis ID
- 05eb9cda006e6cf052f2511e891eee46
Company information
- Manufacturer
- EPS BIO TECHNOLOGY CORP.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- EPS BIO TECHNOLOGY CORP.
Product details
- Intended Use
- It is used for in vitro measurement of blood glucose content in fresh microvascular whole blood samples and is not suitable for neonatal testing.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1345 Glucose Test System
- Import Information
- Domestic
Dates and status
- Registration Date
- May 21, 2013
- Expiry Date
- Jun 01, 2022
- Cancellation Date
- Apr 12, 2024
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Boy's second-generation blood glucose measurement system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 05eb9cda006e6cf052f2511e891eee46 and manufactured by EPS BIO TECHNOLOGY CORP.. The authorized representative in Taiwan is EPS BIO TECHNOLOGY CORP..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices